MedPath

Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Recruiting
Conditions
Neuro-Ophthalmology
Registration Number
NCT04451265
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Patient over 18 years old
  • Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist
  • For which a brain and visual MRI is planned
  • Express consent to participate in the study
  • Affiliate or beneficiary of a Social Security scheme
Exclusion Criteria
  • Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)
  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Study the sensitivity of the High resolution Diffusion sequence in the detection of NOIA, evaluated by a DWI hypersignal and an ADC hyposignal of the optic nervebasline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

CHU de LILLE

🇫🇷

Lille, France

Chu Rouen

🇫🇷

Rouen, France

Fondation A De Rothschild

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath